产KPC肺炎克雷伯菌传播:感染控制措施的作用
本文通过批判性综述过去5年发表的感染控制措施研究,评估控制产KPC肺炎克雷伯菌(KPC-KP)在医疗环境中传播的效果。纳入的11项研究多为无对照组的暴发报告,推荐措施执行频率差异大,患者死亡率达42.9%。结论认为尽管暴发期间控制成功,但个体措施效果难以评估,证据质量低,缺乏对照干预研究。
要点
- KPC-KP暴发中感染控制措施可成功控制传播,但个体措施效果难评估。
- 纳入研究多为无对照组的暴发报告,证据质量低。
- 携带KPC-KP患者死亡率高达42.9%。
核心结论
- 尽管暴发期间KPC-KP传播控制成功,但个体感染控制措施的影响难以评估。
- 已发表证据质量低,缺乏对照干预研究。
- KPC-KP仍是全球主要医疗问题。
研究设计与样本
- 批判性文献综述,评估过去5年发表的感染控制措施研究。
- 纳入11项研究,多数为暴发报告,无对照组。
主要发现
- 推荐措施执行频率存在差异。
- 记录了环境采样和员工筛查等额外措施。
- 手卫生依从性仅在相对较少的研究中测量。
- 携带KPC-KP患者死亡率达42.9%。
临床怎么用
- 临床应执行推荐的感染控制措施以控制KPC-KP暴发。
- 需加强手卫生依从性监测。
局限性
- 纳入研究多为无对照组的暴发报告,证据质量低。
- 缺乏对照干预研究,个体措施效果难以评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The worldwide spread of carbapenemase-producing Gram-negative bacteria (GNB) in healthcare settings is worrying. Of particular concern is the occurrence of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KP). In recent years, several guidelines and recommendations have focused on the control of carbapenem-resistant GNB. It remains, however, unknown to what extent individual infection control measures are effective. Our aim was to critically review the recent evidence regarding the effectiveness of measures to control KPC-KP spread in healthcare settings. METHODS: Critical review of the literature aiming to evaluate, in accordance with published recommendations, all available studies reporting infection control (IC) measures to control KPC-KP published in the past 5 years. RESULTS: Among 11 included studies, the majority consisted of outbreak reports, where application of measures was reported in the absence of control groups. Variability was observed related to the frequency of application of recommended measures for control of KPC-KP. Additional measures were recorded, such as environmental sampling and staff screening, whereas compliance with hand hygiene was measured in relatively few studies. Finally, mortality in patients harbouring KPC-KP was notable, reaching 42.9% of included patients. CONCLUSIONS: Despite successful control of KPC-KP spread during outbreaks, the impact of individual IC measures is difficult to assess, as the quality of published evidence is low and controlled intervention studies are lacking. The distribution of studies, the number of reported cases and the high mortality rates, clearly show that KPC-KP remains a major healthcare problem worldwide.
引用
- Tsioutis C, Eichel VM, Mutters NT, et al. Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control. J Antimicrob Chemother. 2021. PMID: 33534880. doi:10.1093/jac/dkaa492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。